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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The aim of this review is to assess the effects of provision of assistive devices, education on hip precautions, environmental modifications
and training in ADL and EADL for people undergoing hip arthroplasty.
B A C K G R O U N D
Description of the condition
Total hip replacement (THR) surgery involves replacing the
femoral head and acetabular components of the diseased hip joint
with a new artificial joint that replicates the function of the hip.
Usually, the prosthetic hip is constructed fromeithermetal, plastic,
ceramic materials or a combination. Although some THR surgery
is performed following traumatic hip injuries, most THR surgery
is for degenerative hip diseases and is planned in advance. This is
termed ‘elective’ surgery.
THR is one of the most common orthopaedic operations per-
formed worldwide. In 2010, 76,759 THRs were recorded by the
National Joint Registry for England and Wales (National Joint
Registry 2011). Of these, 68,907 were primary (first time) proce-
dures and 7852 were revision (replacement of the prosthesis) surg-
eries. In 2009, the Swedish Joint Registry recorded that 17,521
THR procedures were performed, of which 15,648 were pri-
mary and 1873 were revisions (Swedish JRU 2010). Similarly,
24,253 were performed in Canada (excluding Quebec) in 2006
to 2007 (Canadian Joint Replacement Registry 2009) and more
than 193,000 THRs per annum in the United States of America
(USA) (Graver 2010).
Osteoarthritis is the principal indication for THR, accounting
for between 83% (Swedish JRU 2010) to 93% (National Joint
Registry 2011) of all primary THR procedures. With an ageing
population, increasing rates of obesity, and increasing quality of
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life expectations the annual increase in operative rates is likely to
continue (Birrell 1999; Kurtz 2007). Although THRs are consid-
ered to be one of the most effective orthopaedic procedures per-
formed for relieving pain and improving the quality of people’s
lives (Hawker 2006; McMurray 2000; NICE 2000), their provi-
sion carries substantial associated costs. For example, in the USA,
the cost in 2006 for THR was estimated as $5 billion, of which
70% of the costs related directly to hospital stay (Graver 2010).
Although costs in other developed counties are less, they are still
substantial (Sigurdsson 2008). The high cost of the hospitalisation
phase has resulted in a drive by healthcare providers to reduce the
overall length of stay (Cookson 2011). As a result of this decreased
length of stay, increased emphasis needs to be placed on pre-ad-
mission education services, efficient discharge planning, and im-
mediate post-operative rehabilitation (Westby 2006).
Description of the intervention
Occupational therapists use purposeful activity or interventions
designed to help people perform activities of daily living (ADL)
at home or at work (AOTA 1994). For people undergoing THR,
the interventions provided by occupational therapists generally
aim to improve function and prevent dislocation following hip
arthroplasty. These have been categorised as the following.
• Provision of assistive devices designed to assist ADL (raised
toilet seats, furniture raises, dressing aids, perching stools, long
handled reaches, commodes).
• Post-operative education in joint protection by advising on
following ’hip precautions’ or avoiding specific movements such
as hip flexion beyond 90 °, hip adduction beyond the midline,
and internal and external rotation of the hip beyond 20 ° from
neutral (Lucas 2008).
• Environmental modifications (removal of trip hazards,
layout of furniture to improve access around the home,
installation of handrails or grab rails).
• Training to improve basic ADLs such as washing, dressing,
feeding and toileting.
• Training to improve extended ADL (EADL) or
instrumental ADL (IADL) (e.g. cooking, household activities,
leisure pursuits and community engagement).
• Provision of specific advice about coping strategies to
manage pain.
• Provision of specific advice on how to access other services
for support following THR (e.g. access to other professional
services, for mental well-being).
All these interventions may be provided pre-operatively or post-
operatively, or both, in the acute care system or in the community,
or both.
It has been recommended that post-operative rehabilitation fol-
lowing THR should be delivered by multidisciplinary teams (Tian
2010). This has become commonpractice withinWestern Europe,
USA and Australasia (De Jong 2009; Grotle 2010; Tian 2010).
However, it remains unclear whether this occurs in less developed
nations that do not have access to occupational therapy as a specific
profession (Fudge 1992; Krefting 1992; Wilson-Braun 1992). As
a consequence, the provision of hip precaution equipment and
functional training may be administered by physiotherapists or
nurses rather than occupational therapists. This potential variabil-
ity in the professional group who provide these interventions will
therefore be reflected in this review’s eligibility criteria.
How the intervention might work
Although the overall aims of occupational therapy interventions
may be varied and are patient-centred, in this context their general
aim is to: empower people and reduce anxiety through education,
provide advice post-operatively, maximise independence through
training in EADL and IADL skills with a graded approach de-
pendent on patients’ capabilities during their recovery, enhance
participation with increased functional capability through advice,
training and preparation for hospital discharge (Orpen 2010). A
variety of interventions may be used to reduce the risk of pros-
thesis dislocation. These can include education on which specific
movements should be avoided to reduce the risk of prosthesis dis-
location, and the provision of equipment such as raised toilet seats,
furniture raises, perching stools and long handled reaches to avoid
hip flexion over 90 ° (Drummond 2012). The assessment and
provision of environmental adaptations such as removal of trip
hazards, evaluation of the layout of furniture and installation of
handrails or grab rails may be useful to reduce the risk of falls and
facilitate functional capability during the recovery period (Pighills
2011).
Why it is important to do this review
A recent survey of occupational therapists working in orthopaedic
settings in the United Kingdom (UK) reported that, on average,
peoplewhohave hadTHRcomprise 40%of their caseload, despite
a paucity of evidence on the clinical or cost-effectiveness of occu-
pational therapy interventions (Drummond 2012). The majority
of reviews to date that investigate rehabilitation following THR
have focused predominantly on physiotherapy, exercise, pre-op-
erative education, or multidisciplinary rehabilitation programmes
(Ackerman 2004; Coudeyre 2007; Dauty 2007;DiMonaco 2009;
Kuster 2002). Previous Cochrane systematic reviews that have ad-
dressed pre-operative education (McDonald 2004) and multidis-
ciplinary rehabilitation programmes (Khan 2008) specifically ex-
cluded uni-disciplinary interventions and included studies that
contained both THR and knee replacement populations. Further-
more, a protocol for a review of post-acute physiotherapy for THR
patients is awaiting publication (Westby 2006). However, no re-
view of the post-operative occupational therapy interventions for
2Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and improve function after hip
arthroplasty (Protocol)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
people following THR has been undertaken. This was reiterated
by Steultjens 2005 who assessed the efficacy of occupational ther-
apy for different conditions. They concluded that no reviews have
been undertaken on occupational therapy rehabilitation for peo-
ple following THR (Steultjens 2005).
Therefore, despite endorsements in the UK by NICE (NICE
2003) and the British Orthopaedic Association (BOA) (British
Orthopaedic Association 2006) for the provision of assistive de-
vices as a key aspect of occupational therapy in THR rehabilita-
tion, there has been no specific assessment of the evidence base to
underpin these recommendations. As a result, existing protocols
on occupational therapy management following THR have been
based on clinical experience, surgeon preference, or anecdotal re-
ports (Westby 2006). TheUKCollege of Occupational Therapists
recognised the limitations in practice guidelines and subsequently
recently released their first clinical guidelines on this topic (College
of Occupational Therapists 2012). They recommend the applica-
tion of the interventions acknowledged above, but acknowledge
the paucity of literature evaluating the effectiveness of these inter-
ventions for people following THR.
O B J E C T I V E S
The aim of this review is to assess the effects of provision of assis-
tive devices, education on hip precautions, environmental modi-
fications and training in ADL and EADL for people undergoing
hip arthroplasty.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (patient and cluster) and quasi-ran-
domised trials will be included. Quasi-randomised trials are those
where the generated sequence to allocate participants is not strictly
random, for example by hospital number. Non-randomised con-
trolled trials will be excluded. There will be no restriction on the
inclusion of studies based on the language that papers are pub-
lished in or the publication status of studies.
Types of participants
Participants undergoing primary or revision THR surgery for os-
teoarthritis. Excluding studies that have included a few partici-
pants who have received a THR for reasons other than osteoarthri-
tis could limit the available information to be included in this
review. Therefore, studies will be included if the majority of par-
ticipants (> 80%) received THR surgery for osteoarthritis. Trials
which include various pathologies and various orthopaedic surg-
eries (that is total knee replacements, hip resurfacing, hemi-arthro-
plasty) will be included if the results for THR for osteoarthritis
are presented separately. All types of prostheses, fixation methods
and surgical approaches will be considered for inclusion.
Types of interventions
We will include studies examining one or more of the following
interventions.
• Provision of and education about using assistive devices for
preventing dislocation. Such assistive devices may therefore
include: raised toilet seats, furniture raises, dressing aids,
perching stools, long handled reachers and commodes.
• Post-operative education about hip precautions and
specifically on teaching joint positions associated with joint
dislocation (hip flexion beyond 90 °, adduction beyond the
midline, and to avoid internal and external rotation beyond 20 °
from neutral (Lucas 2008)).
• Environmental modifications such as removal of trip
hazards; layout of furniture to improve access around the home;
layout of specific rooms such as bathrooms, the kitchen and
bedroom; and installation of handrails or grab rails.
• Assessment, facilitation, practice and re-assessment of self-
care ADL tasks to foster independence and skills in these
activities.
• Training of EADL or IADL skills aimed at improving
health-related quality of life (HRQOL). This will include
specific training to facilitate activities beyond personal or self-
care ADLs. This may therefore include activities such as
gardening, shopping and social pursuits.
• Provision of specific advice about coping strategies to
manage pain and activity pacing.
• Post-operative education sessions designed to inform
patients of their expected pathway from the operative procedure
to recovery at home to reduce anxiety and improve preparation
for hospital discharge, and specific advice on how to access other
services for support following THR (e.g. access to other
professional services).
These interventions are applied post-operatively, in a healthcare
setting or in any community setting. Trials looking at complex
packages of care delivered by multidisciplinary teams will also be
included if the effect of the occupational therapy interventions
can be independently evaluated. Interventions provided by ther-
apy assistants under the supervision of qualified occupational ther-
apy staff will be accepted. In some countries, interventions pro-
vided by healthcare staff other than designated occupational ther-
apists, which are commensurate with accepted occupational ther-
apy practice, will be accepted. Any studies of this nature will be as-
sessed by one review author (AD) to ensure the intervention meets
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accepted occupational therapy practice. Occupational therapy in-
terventions provided as part of a multidisciplinary package will be
accepted if the nature of the occupational therapy intervention is
adequately described and the outcome can be assessed indepen-
dently or, if it cannot be isolated, the occupational therapy aspects
of the study constitute more than 75% of the time allocated to the
whole multidisciplinary intervention package. If the nature of the
occupational therapy intervention cannot be isolated, or forms less
that 75% of the overall intervention package, the study will be ex-
cluded. Trials investigating education interventions provided pre-
operatively will not be included in this review since this has been
previously investigated in another Cochrane review (McDonald
2004).
Comparison interventions will include:
• rehabilitation therapy excluding the interventions of interest
(assistive devices, hip precautions, environmental modifications);
• no rehabilitation therapy provided;
• one intervention of interest versus another.
Types of outcome measures
The main outcomes will be the following.
1. Pain as measured with tools such as a visual analogue or
rating scale, or formal tools such as the McGill Pain
Questionnaire (Melzack 1971).
2. Function, as measured by WOMAC function (Bellamy
1988); Oxford Hip Score (Dawson 1996); Harris Hip Score
(Harris 1969); Short Form (SF)-36 Physical Component Score
(Stewart 1988); Health Assessment Questionnaire (Fries 1980);
any other function scale.
3. Health-related quality of life (e.g. SF-36 (Stewart 1988),
SF-12 (Ware 1996), Frenchay Activities Index (Schuling 1993),
EuroQoL, Nottingham Health Profile (NHP) (Hunt 1980)).
4. Global assessment of treatment success.
5. Hip dislocation, as reported (e.g. the number of
participants requiring a manipulation under anaesthetic to
reduce a dislocated hip prosthesis, or the requirement of a
revision procedure due to recurrent hip dislocation.
6. Reoperation rate.
7. Total adverse events (e.g. infection, thrombosis, falls).
Minor outcome measures will be the following.
1. Limitations in personal ADLs during the initial six weeks,
which are defined as the basic activities which everyone
undertakes to maintain a personal level of care (e.g. feeding,
toileting, washing, bathing, transfer in and out bed or a chair,
mobilising). Personal ADLs may be assessed using instruments
such as the Barthel Score (Collin 1988) or Iowa Level of
Assistance Score (Shields 1995).
2. Restrictions in performance in extended (EADLs) or
instrumental activities of daily living (IADLs), which are defined
as the skills required to live independently and manage a dwelling
(e.g. preparing own meals, doing housework, managing own
money, shopping). This may be assessed using instruments such
as the Oxford Hip Score (Dawson 1996) or the Nottingham
extended activities of daily living scale (Nouri 1987).
3. Societal reintegration or discretionary activities. These are
the higher function activities such as driving, using local services,
using public transport, socialising with friends, attending social
or cultural events. This outcome measure differs from specific
health-related quality of life (HRQOL) measures since this
outcome specifically relates to social interaction and
participation activities rather than more generic activities of daily
living, which are captured through the HRQOL outcomes.
4. Length of hospital stay following the surgical procedure.
5. Cost-analysis. This will include specific occupational
therapy costs, overall rehabilitation costs, or overall hospital costs.
Main outcomes will be reported through the use of a ’Summary
of findings’ table. Minor outcomes will also be reported through
the use of ’Additional tables’.
A wide variation in outcome measures exist that measure ADL,
EADL and IADL, QOLand pain. All validated outcomemeasures
will be analysed. The decision to analyse or reject non-validated
measures will be made by consensus across the review team. The
decision to reject or accept non-validated measures will be made
before the review authors examine the results of the trials.
Follow-up time points
It is common in rehabilitation trials for outcome data to be col-
lected at multiple follow-up time points. If included trials mea-
sure outcomes at more than one time point, we will categorise the
follow-up time points as:
• short term (less than six weeks following THR surgery);
• intermediate term (six weeks to six months following THR
surgery);
• long term (greater than six months following THR surgery).
In the case of multiple time points within a category (for exam-
ple four-week and five-week measurements in the short term cat-
egory), we will extract the last time point (that is five weeks).
Search methods for identification of studies
Electronic searches
The following electronic databases will be used to identify relevant
studies published from database inception to the present:
• Cochrane Central Register of Controlled Trials
(CENTRAL) in The Cochrane Library;
• MEDLINE via Ovid;
• EMBASE via Ovid;
• CINAHL plus (Cumulative Index to Nursing and Allied
Health Literature) via EBSCOhost;
4Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and improve function after hip
arthroplasty (Protocol)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• AMED (Allied and Complementary Medicine Database)
via EBSCOhost;
• PEDro (Physiotherapy Evidence database) via http://
www.pedro.org.au/;
• ERIC (Education Resources Information Centre) via
ProQuest;
• CIRRIE (Centre for International Rehabilitation Research
Information and Exchange) via http://cirrie.buffalo.edu/
database/;
• Web of Science via http://apps.webofknowledge.com/;
• OTDbase via http://www.otdbase.org/.
The electronic search strategy for MEDLINE is outlined in
Appendix 1. This search strategy will be adapted for other
databases.
The reference lists of included articles will be searched to as-
certain if any relevant trials have not been identified by the
electronic searches. Ongoing trials will be searched for through
trials registers and their respective websites: Controlled Clini-
cal Trials (www.controlled-trials.com), the National Institutes of
Health Trial Registry (http://clinicaltrials.gov), and the Inter-
national Clinical Trials Registry Platform of the World Health
Organization (http://apps.who.int/trialsearch/). Grey literature
will be searched for using the OpenGrey database (http://
www.opengrey.eu/).
Searching other resources
Conference abstracts from the European League Against Rheuma-
tism (EULAR) and the Society of Research in Rehabilitation
(SRR) will be searched to identify other unpublished studies from
the earliest abstract archive (2005 and 2001 respectively) to the
present. Citations of key articles will be checked using the Web of
Science citation search facility. National and international experts
in occupational therapy orthopaedic research will be contacted for
any knowledge of ongoing studies, published data not available
electronically, or unpublished work.
Data collection and analysis
Selection of studies
Three review authors (TS, PJ, GS) will independently screen all
titles and abstracts identified from the search against the selection
criteria. Three review authors (TS, PJ, GS) will independently se-
lect studies as possibly relevant (those that meet the criteria and
those where insufficient information is provided to definitively
exclude studies based on title and abstract) and excluded (those
clearly not meeting the selection criteria). The full text papers for
all studies deemed possibly relevant will be obtained and the three
review authors (TS, PJ, GS) will independently assess whether
they meet the selection criteria. If necessary, further information
will be sought from authors to determine if the study meets the
inclusion criteria. A researcher and registered occupational ther-
apist (AD) will be consulted about uncertainty on occupational
therapy involvement in the study. If the three primary review au-
thors cannot reach agreement about suitability for inclusion, this
will be resolved by a fourth review authors (AD). We will record
the selection process in sufficient detail to complete a PRISMA
flow diagram and ’Characteristics of excluded studies’ table.
Data extraction and management
All papers meeting the inclusion criteria will be reviewed in full
by the same three review authors (TS, PJ, GS), who will indepen-
dently extract information from each included study and record
this on pre-prepared data extraction forms. The data to be ex-
tracted will be: setting (geographic location of study: acute hos-
pital, rehabilitation hospital, community or domiciliary), popu-
lation characteristics (age, gender, co-morbidities), nature of the
intervention and control (pre or post-operative, or both; multi-
disciplinary or occupational therapy only), number and duration
of patient contacts, nature of occupational therapy intervention,
sample size, outcome measures used, and timing of follow-up as-
sessments). The risk of bias data to be extracted will be based on
the domains itemised in the Cochrane risk of bias tool (Higgins
2011) detailed below. Any disagreements will be resolved by the
two primary review authors reaching a consensus decision. If dis-
agreement persists, one of the three expert review authors (CS,
ED or ADB) will be consulted. Any disagreement specifically sur-
rounding occupational therapy practice will be discussed first with
the occupational therapy expert (AD) before arbitration by the
expert review authors. Study authors will be contacted and asked
to provide additional data and to clarify methods if insufficient
detail is in the published report.
A priori decision rules were established to assist in selecting which
data to extract in the event of multiple outcome reporting.
• Where trialists reported outcomes for more than one pain
score, we will extract data on the scale highest on the following
list: (i) visual analogue or rating scale; (ii) formal tools such as
the McGill Pain Questionnaire; (iii) any other pain score.
• Where trialists reported outcomes for more than one
function scale, we will extract data on the scale that is highest on
the following list: (i) WOMAC function; (ii) Oxford Hip Score;
(iii) Harris Hip Score; (iv) SF-36 Physical Component Score; (v)
Health Assessment Questionnaire; (vi) any other function scale.
• Where trialists reported outcomes for more than one
limitation in personal ADL score, we will extract data on the
scale highest on the following list: (i) Iowa Level of Assistance
Score; (ii) Barthel Score; (iii) any other personal ADL score.
• Where trialists reported outcomes for more than one
HRQOL scale, we will extract data on the scale highest on the
following list: (i) SF-36; (ii) SF-12; (iii) Frenchay Activities
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Index; (iv) EuroQoL; (v) Nottingham Health Profile; (vi) any
other HRQOL scale.
• Where trialists reported outcomes for more than one
limitation to extended ADL score, we will extract data on the
scale highest on the following list: (i) Oxford Hip Score; (ii) the
Nottingham extended activities of daily living scale; (iii) any
other extended ADL score.
• If both final values and change from baseline values are
reported for the same continuous outcome, we will use final
scores rather than change from baseline scores.
• If both unadjusted and adjusted values for the same
outcome are reported, we will report the unadjusted values but
also extract adjusted values for sensitivity analyses.
• If data are analysed based on an intention-to-treat (ITT)
sample and another sample (e.g. per protocol, as treated), we will
report the ITT sample but also extract the per protocol or as
treated sample and analyse the results as a sensitivity analysis.
Assessment of risk of bias in included studies
The Cochrane risk of bias tool (Higgins 2011) will be used to
assess the quality of the included studies. The domains that will
be assessed are:
• random sequence generation;
• allocation concealment;
• blinding of outcome assessment;
• incomplete outcome data;
• selective reporting;
• other potential sources of bias.
In rehabilitation trials it is not usually possible for the participants
or the study personnel to remain blinded from the intervention,
however we will evaluate the ‘blinding of participants and per-
sonnel’ domain as the study may still be subject to performance
bias even if it is not possible to blind the participants. Blinding
of the outcome assessors is practicable and is considered highly
important when using subjective outcomes (Boutron 2006). Fur-
thermore, we will separately assess blinding of self-reported sub-
jective outcomes (such as pain, function, HRQOL) and blinding
of independent outcome assessors of objective outcomes (such as
reoperation rate, adverse events).
The quality of the study for each domain will be assessed by three
independent review authors (TS, PJ, GS) and will be rated as low
risk of bias, high risk of bias, or unclear risk of bias. If the three
independent review authors are unable to agree, disagreements will
be resolved by a fourth review author (CS).
Measures of treatment effect
Analyses will be based on the ITT data from the included studies.
We will express dichotomous outcome data (such as frequency of
prosthesis dislocation, adverse events) as risk ratios (RR) with 95%
confidence intervals (CI) and continuous outcomes (such as the
visual analogue pain score, Oxford Hip Score, McGill Pain Ques-
tionnaire) as mean differences (MD) with 95% CI for continuous
outcomes if the same scale is used to measure the same outcome
across studies. Where different scales are used to measure the same
outcome the standardised mean difference (SMD) with 95% CI
will be used. To enhance interpretability of results, pooled SMDs
will be back-transformed to a representative original scale, highest
on the prior hierarchy of outcomes reported, by multiplying the
SMD and 95% CI by a representative standard deviation (SD) at
baseline from one of the included trials.
The results of the review will be presented separately by interven-
tion to assess the effectiveness of each intervention.
Unit of analysis issues
The unit of analysis will be the participant, and a single measure-
ment for each outcome from each participant will be analysed.
Therefore, participants who have bilateral THR will be analysed
as a single measurement. In the event of data not being presented
by the individual participant, specific corresponding authors will
be contacted to obtain these data at a participant rather than THR
unit level.
Dealing with missing data
An attempt will be made to contact authors of studies withmissing
data and an ITT analysis will be performed where possible. For
dichotomous outcomes, the number of participants allocated to
each group will be used as the denominator for all analyses. For
missing data, the assumption will be made that all patients had
the worst possible outcome. For continuous outcomes with no
standard deviations reported, we will calculate these from standard
errors, confidence intervals or P values if reported. If it is not
possible to calculate standard deviations, we will first try to use
baseline standard deviations; if this is not possible, we will impute
standard deviations from other hip replacement studies. However,
no attempt at imputation will be made if several studies have
missing data.
Assessment of heterogeneity
All included trials will first be assessed for clinical homogeneity in
terms of participants, interventions and comparators by a consen-
sus decision. Studies judged to be homogeneous will be assessed
for the potential statistical variability of the treatment effects due
to heterogeneity via calculation of the I2 statistic. This measure
describes the percentage total variation across studies that results
from heterogeneity rather than chance. The following guidelines
will be used for interpretation (Deeks 2008): 0% to 40% may be
unimportant; 30% to 60% may represent moderate heterogene-
ity; 50% to 90% may represent substantial heterogeneity; 75% to
100%considerable heterogeneity. The content of the occupational
therapy interventions in the included studies will be analysed and
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matched to one or more of the categories listed in the ’Types of
Interventions’ section.
Studies will be combined for analysis in the following way.
1. Studies that contain the same intervention only.
2. Studies that combine training for basic ADLs with training
for EADLs or IADLs.
3. Complex occupational therapy interventions which contain
elements that match multiple categories.
Assessment of reporting biases
The clinical trials register at the International Clinical Trials
Registry Platform of the World Health Organization (http://
apps.who.int/trialsearch/) will be searched to evaluate if selected
reporting of outcomes is present (outcome reporting bias). If 10
or more studies are included in the meta-analyses, the data will be
examined for reporting bias via visual inspection of a funnel plot.
We will assess the presence of small study bias in the overall meta-
analysis by checking if the random-effects model estimate is more
beneficial than the fixed-effect model estimate (Sterne 2011).
Data synthesis
Data will be analysed using Review Manager 5.2 (RevMan 2012).
Data from individual trials will only be combined for meta-anal-
yses if the interventions, patient groups and outcomes are suffi-
ciently similar. This will be determined by a consensus decision
amongst the review authors.No results of anymeta-analysis under-
taken will be reported if the I2 statistic is greater than 75%. A ran-
dom-effects model will be used as the default analytical method-
ology.
We may find too much heterogeneity amongst outcome measures
used (diversity of measures, in presentation of results) to make
quantitative analysis (meta-analysis) appropriate. In addition, we
anticipate that many studies may have samples sizes too small to
fulfil the underlying assumption required for quantitative meta-
analysis, which is that the results are normally distributed. The
skew ratio (Altman 1996) will be calculated for each study and
if a ratio of less than two exists, the studies will not be used for
quantitative analysis.
Subgroup analysis and investigation of heterogeneity
If sufficient numbers of trials are identified, the following subgroup
analyses will be conducted.
• Primary versus revision THR procedure.
• Delivery of the intervention by occupational therapists or
other health professionals.
• Comparison of multiple interventions (e.g. assistive devices
plus hip precautions plus environmental modifications) versus
single interventions alone.
Sensitivity analysis
If sufficient trials are included in the review, a sensitivity analysis
for the effects of adequate allocation concealment on the treatment
effect for the main outcome measurements will be performed. Re-
moval from the meta-analyses of trials identified in the risk of bias
section as having inadequate or unclear allocation concealment
may influence the analysis of the overall treatment effect. We will
perform a sensitivity analysis to account for the removal of small
sample size studies following the skew ratio calculation, as outlined
in the Data synthesis section. We will also perform a sensitivity
analysis to analyse the effect of adequate blinding of self-reported
subjective outcomes (e.g. pain, function, HRQOL) on treatment
effects.
Presentation of key results
We will present the main results of the review in a summary of
findings (SoF) table, which provides key information concerning
the quality of the evidence, themagnitude of effect of the interven-
tions examined, and the sum of available data measuring changes
in all outcomes, as recommended by The Cochrane Collaboration
(Schünemann 2011a). The outcomes we plan to present in this
table include: (i) pain; (ii) function; (iii) HRQOL; (iv) global as-
sessment of treatment success; (v) reoperation rate; (vi) hip dislo-
cation; and (vii) adverse events (including infection, thrombosis,
falls). The SoF table includes an overall grading of the evidence
related to each of themain outcomes using the GRADE approach,
which assesses study limitations, consistency of effect, imprecision,
indirectness and publication bias (Schünemann 2011b). For all
outcomes, data for the latest time point available will be included.
In the ’Comments’ column of the SoF table, we will provide: the
absolute per cent difference, the relative per cent change from
baseline, and the number needed to treat (NNT) (theNNTwill be
provided only when the outcome shows a statistically significant
difference between interventions groups).
For dichotomous outcomes, such as adverse events, the num-
ber needed to treat will be calculated from the control group
event rate and the relative risk using the visual treatment NNT
calculator (Cates 2008). The NNT for continuous measures
will be calculated using the Wells calculator (available at the
CochraneMusculoskeletal Group (CMSG) Editorial office, http:/
/musculoskeletal.cochrane.org/).
For dichotomous outcomes, the absolute risk difference will be
calculated using the risk difference statistic in RevMan and the
result expressed as a percentage. For continuous outcomes, the
absolute benefit will be calculated as the improvement in the in-
tervention group minus the improvement in the control group, in
the original units.
The relative per cent change for dichotomous data will be calcu-
lated as the risk ratio - 1 and expressed as a percentage. For contin-
uous outcomes, the relative difference in the change from baseline
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will be calculated as the absolute benefit divided by the baseline
mean of the control group.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Study type
1 RANDOMIZED CONTROLLED TRIAL.pt.
2 CONTROLLED CLINICAL TRIAL.pt.
3 RANDOMIZED CONTROLLED TRIALS.sh.
4 RANDOM ALLOCATION.sh.
5 DOUBLE BLIND METHOD.sh.
6 SINGLE BLIND METHOD.sh.
7 or/1 6
8 ANIMALS.sh. not HUMANS.sh.
9 7 not 8
phase 2:
10 CLINICAL TRIAL.pt.
11 exp CLINICAL TRIALS/
12 (clin$ adj25 trial$).ti,ab.
13 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
14 PLACEBOS.sh.
15 placebo$.ti,ab.
16 random$.ti,ab.
17 RESEARCH DESIGN.sh.
18 or/10 17
19 18 not 8
20 19 not 9
phase 3:
21 COMPARATIVE STUDY.sh.
22 exp EVALUATION STUDIES/
23 FOLLOW UP STUDIES.sh
24 PROSPECTIVE STUDIES.sh
25 (control$ or prospectiv$ or volunteer$).ti,ab.
26 or/21 25
27 26 not 8
28 27 not (9 or 20)
29 9 or 20 or 28 (to combine all 3 phases)
AND (Intervention - occupational therapy)
1 OCCUPATIONAL THERAPY.sh.
2 SELF-HELP DEVICES.sh.
3 SPLINTS.sh.
4 (occupational adj1 therap$).ti,ab.
5 splint$.ti,ab.
6 ((assist$ or help$) adj5 (device$ or technolog$)).ti,ab.
7 ((sel$ or home$) adj5 (care$ or manage$)).ti,ab.
8 ((environment$ or home$ or domestic$ or house$) adj5 (adapt$)).ti,ab.
9 ((daily or domestic$ or house$ or home$) adj5 (activit$ or task$ or skill$ or chore$)).ti,ab.
10 or/1 9
AND participants
1 ARTHROPLASTY, REPLACEMENT, HIP.sh.
2 ARTHROPLASTY, REPLACEMENT, knee.sh.
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3 KNEE PROSTHESIS.sh.
4 HIP PROSTHESIS.sh
5 ((hip$ or knee$) adj10 (replace$ or arthroplast$ or prosthe$ or implant$)).ti,ab.
6 ((femor$ or hip$ or acetabul$ or knee$ or tibia$ or fibular$) adj5 (fracture$ or dislocat$)).ti,ab.
7 ((arthritis) and (hip$ or knee$).ti,ab.
The search strategy has included search terms targeted at finding studies relating to knee replacements so that studies including both
people with hip and knee replacements are not excluded at this stage of the search process.
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